BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 14, 2011
View Archived Issues
OTS-11101 is well tolerated in first-in-human study in solid tumors
Read More
LY-2523355 advances in phase I trial in advanced/metastatic malignancies
Read More
Merck & Co. prepares novel adenosine A2A receptor antagonists
Read More
Genosco and Oscotec disclose new protein kinase inhibitors
Read More
Sirtris Pharmaceuticals presents new SIRT1 activators
Read More
Bristol-Myers Squibb patents new lysophospholipid S1P1 receptor agonists
Read More
EPI-743, a natural metabolite and orphan drug in inherited mitochondrial respiratory chain diseases
Read More
Metreleptin shows promise in partial lipodystrophy and amenorrhea
Read More
FDA accepts Adamis Pharmaceuticals' IND for APC-100 for prostate cancer
Read More
Phase I trial of Medicago's H1N1 flu vaccine shows safety and solid immune response
Read More
New putative biomarkers of systemic sclerosis identified
Read More
Bristol-Myers Squibb designs new series of HCV NS5A inhibitors
Read More
Scientists at Lilly describe novel opioid NOP receptor antagonists
Read More
Bionomics and Merck Serono extend MS collaboration
Read More
Forest Laboratories to launch Daliresp in U.S. this month
Read More
Two Morphotek products obtain FDA orphan drug status
Read More
FDA grants orphan drug status to Aradigm's ciprofloxacin for inhalation in bronchiectasis
Read More
Emergent BioSolutions' anthrax vaccine NuThrax gets FDA fast track status
Read More
First part of ivacaftor/VX-809 phase II trial in cystic fibrosis meets primary endpoints
Read More
Roche to make first milestone payment to Evolva in drug discovery collaboration
Read More
Synthes and Eli Lilly sign agreement focused on osteoporosis and bone fractures
Read More
Chugai provides update on application in Japan for Epogin in chemotherapy-induced anemia
Read More
Cell Therapeutics meets with FDA to discuss resubmission of pixantrone NDA
Read More
FDA approves Potiga as adjunctive treatment for partial-onset seizures
Read More
French and German authorities suspend use of pioglitazone-containing products
Read More
